A recent study of a thrombolysis protocol for patients with acute stroke, and an accompanying editorial, prompted debate about the safety and efficacy of tissue plasminogen activator in stroke, and the data supporting its use for this indication. (MJA 2007; 187: 567-570 and 548-549)
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
